U.S. CDC recommends use of Novavax's COVID-19 shot for adolescents

The U.S. Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc's COVID-19 vaccine for adolescents aged 12 through 17.

The recommendation follows the U.S. Food and Drug Administration's authorization for the vaccine for the age group earlier this month.